Litcius/Paper detail

Toxicity and Patient-Reported Quality-of-Life Outcomes After Prostate Stereotactic Body Radiation Therapy With Focal Boost to Magnetic Resonance Imaging-Identified Prostate Cancer Lesions: Results of a Phase 2 Trial

Brett Morris, Emma E. Holmes, N. Anger, Gregory Cooley, Jéssica Schuster, Newton J. Hurst, Andrew M. Baschnagel, M. Bassetti, Grace C. Blitzer, Richard J. Chappell, R. A. Bayliss, Zachary S. Morris, Mark A. Ritter, John M. Floberg

2023International Journal of Radiation Oncology*Biology*Physics13 citationsDOI

Topics & Concepts

Prostate cancerProstateMedicineMagnetic resonance imagingRadiation therapyQuality of life (healthcare)CancerRadiologyOncologyInternal medicineNursingProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchAdvanced Radiotherapy Techniques
Toxicity and Patient-Reported Quality-of-Life Outcomes After Prostate Stereotactic Body Radiation Therapy With Focal Boost to Magnetic Resonance Imaging-Identified Prostate Cancer Lesions: Results of a Phase 2 Trial | Litcius